Ravi Shankar Prasad Singh (Ravi Shankar P Singh)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

High Resolution Mass Spectrometry

Pluripotent Stem Cells

Coronavirus Disease

Top Venues

Clinical pharmacology and therapeutics

Drug metabolism and disposition: the biological fate of chemicals

This page only lists publications with an associated author ORCID identifier.

Publications

Aarti Sawant-Basak, Shweta Urva, Jatinder Kaur Mukker, Sebastian Haertter, Dean Mariano, Dolly A Parasrampuria, Kosalaram Goteti, Ravi Shankar Prasad Singh, Manoj S Chiney, Michael Z Liao, Sandy S Chang, Rashmi Mehta
Role of Clinical Pharmacology in Diversity and Inclusion in Global Drug Development: Current Practices and Industry Perspectives: White Paper. Clinical pharmacology and therapeutics (2024)
Katty Wan, Olga Kavetska, Bharat Damle, Haihong Shi, Donna S Cox, Olayide Oladoyinbo, Phylinda Chan, Ravi Shankar Prasad Singh, Susan Craft, Erwin Berthier, Brian Corrigan
Patient Centric Microsampling to Support Paxlovid Clinical Development: Bridging and Implementation. Clinical pharmacology and therapeutics (2023)
Heather Eng, Alyssa L Dantonio, Eugene P Kadar, R Scott Obach, Li Di, Jian Lin, Nandini C Patel, Britton Boras, Gregory S Walker, Jonathan J Novak, Emi Kimito, Ravi Shankar Prasad Singh, Amit S Kalgutkar
Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and Humans. Drug metabolism and disposition: the biological fate of chemicals 50 (5) (2022)
Ravi Shankar Prasad Singh, Gregory S Walker, Eugene P Kadar, Loretta M Cox, Heather Eng, Raman Sharma, Arthur J Bergman, Lien Van Eyck, Frances Hackman, Sima S Toussi, Amit S Kalgutkar, R Scott Obach
Metabolism and Excretion of Nirmatrelvir in Humans Using Quantitative Fluorine Nuclear Magnetic Resonance Spectroscopy: A Novel Approach for Accelerating Drug Development. Clinical pharmacology and therapeutics 112 (6) (2022)